We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+13.58%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62B
AUM Growth
+$4.39B
Cap. Flow
-$1.97B
Cap. Flow %
-3.18%
Top 10 Hldgs %
43.7%
Holding
1,103
New
130
Increased
284
Reduced
500
Closed
130

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$218M
2
PH icon
Parker-Hannifin
PH
+$155M
3
ILMN icon
Illumina
ILMN
+$80.7M
4
DIS icon
Walt Disney
DIS
+$74.2M
5
AZEK
The AZEK Co
AZEK
+$56.4M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$819M
2
META icon
Meta Platforms (Facebook)
META
+$338M
3
MSFT icon
Microsoft
MSFT
+$131M
4
AMZN icon
Amazon
AMZN
+$106M
5
CRM icon
Salesforce
CRM
+$93.2M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Communication Services 16.35%
3 Consumer Discretionary 16.22%
4 Healthcare 12.62%
5 Financials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLNE icon
76
Hamilton Lane
HLNE
$5.57B
$75.4M 0.12%
942,945
-16,849
-2% -$1.21M
CHDN icon
77
Churchill Downs
CHDN
$6.12B
$74.5M 0.12%
534,995
-5,197
-1% -$711K
BOX icon
78
Box
BOX
$4.6B
$74.3M 0.12%
2,527,591
-60,089
-2% -$1.66M
BRBR icon
79
BellRing Brands
BRBR
$1.34B
$73.9M 0.12%
2,019,723
+34,242
+2% +$1.23M
CHX
80
DELISTED
ChampionX
CHX
$73.8M 0.12%
2,378,502
-118,981
-5% -$3.28M
WSC icon
81
WillScot Mobile Mini Holdings
WSC
$4.41B
$72.8M 0.12%
1,523,417
-551,362
-27% -$24.7M
CWST icon
82
Casella Waste Systems
CWST
$5.69B
$72M 0.12%
795,788
-126,031
-14% -$11.2M
MMSI icon
83
Merit Medical Systems
MMSI
$5.32B
$68.5M 0.11%
818,917
-7,572
-0.9% -$616K
FCN icon
84
FTI Consulting
FCN
$4.18B
$68.4M 0.11%
359,419
-91,225
-20% -$17.2M
EVH icon
85
Evolent Health
EVH
$447M
$67.9M 0.11%
2,241,420
-37,407
-2% -$1.21M
AIN icon
86
Albany International
AIN
$1.78B
$66.4M 0.11%
712,350
+34,323
+5% +$3.09M
ABEV icon
87
Ambev
ABEV
$46.4B
$66.3M 0.11%
20,851,526
-120,937
-0.6% -$356K
AZEK
88
DELISTED
The AZEK Co
AZEK
$66.1M 0.11%
+2,181,837
New +$56.4M
CRSP icon
89
CRISPR Therapeutics
CRSP
$5.17B
$64.4M 0.1%
1,147,929
-8,881
-0.8% -$504K
AXNX
90
DELISTED
Axonics, Inc. Common Stock
AXNX
$64.3M 0.1%
1,273,767
-224,927
-15% -$12M
NOVT icon
91
Novanta
NOVT
$6.29B
$64M 0.1%
347,877
-3,217
-0.9% -$526K
ELF icon
92
e.l.f. Beauty
ELF
$5.81B
$63.7M 0.1%
557,535
-5,191
-0.9% -$500K
ACHC icon
93
Acadia Healthcare
ACHC
$2.94B
$62.5M 0.1%
785,047
-111,207
-12% -$8.04M
CALY
94
Callaway Golf Company
CALY
$3.14B
$62.5M 0.1%
3,147,206
-48,130
-2% -$963K
EL icon
95
Estee Lauder
EL
$32B
$61.6M 0.1%
313,628
-340,780
-52% -$72.3M
RBC icon
96
RBC Bearings
RBC
$18B
$61.3M 0.1%
282,073
-113,036
-29% -$24.5M
NE icon
97
Noble Corp
NE
$6.51B
$61.3M 0.1%
1,482,878
+144,363
+11% +$5.56M
MGY icon
98
Magnolia Oil & Gas
MGY
$5.94B
$59.7M 0.1%
2,857,098
+165,796
+6% +$3.43M
UTHR icon
99
United Therapeutics
UTHR
$23.1B
$59.7M 0.1%
270,283
+11,044
+4% +$2.45M
SMPL icon
100
Simply Good Foods
SMPL
$982M
$59.3M 0.1%
1,620,890
-100,713
-6% -$3.7M

Similar funds

Loomis, Sayles & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Loomis, Sayles & Company held 1,103 positions worth $62B, up 7.6% from $57.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Loomis, Sayles & Company withdrew a net $1.97B in Q2 2023, closing 130 positions and reducing 500 holdings. Its most notable exit was Halozyme, an estimated $81.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Loomis, Sayles & Company opened a new position in The AZEK Co worth $66.1M.

  • Loomis, Sayles & Company's largest Q2 2023 buy was The AZEK Co: 2,181,837 shares worth $66.1M.
  • Loomis, Sayles & Company added most to Tesla in Q2 2023, an estimated $218M increase.
  • Loomis, Sayles & Company's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $819M.
  • Loomis, Sayles & Company fully exited Halozyme in Q2 2023, selling an estimated $81.3M.
  • Loomis, Sayles & Company's ten largest holdings make up 44% of its $62B portfolio in Q2 2023.
  • Loomis, Sayles & Company opened 130 new positions and closed 130 in Q2 2023.
  • Loomis, Sayles & Company's portfolio value rose 7.6% quarter-over-quarter to $62B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.